Accessibility settings

This paper is in the following e-collection/theme issue:

Proposals (non-eHealth) (164) Clinical Cancer Research (261) Precision Medicine and Genetics (108) Postoperative Monitoring and Telemonitoring (272) ENT (Ear, Nose, Throat) (51) Pilot studies (non-ehealth) (258)

Published on in Vol 15 (2026)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/89973, first published .
JMIR Publications logo: Advancing Digital Health & Open Science

Evaluation of the Clinical Utility of Circulating Tumor DNA in the Management of Patients With Nonmetastatic Head and Neck Cancer: Protocol for a Prospective Bicentric Study (CIRVAD)

Evaluation of the Clinical Utility of Circulating Tumor DNA in the Management of Patients With Nonmetastatic Head and Neck Cancer: Protocol for a Prospective Bicentric Study (CIRVAD)

Authors of this article:

Romina Mastronicola1, 2 Author Orcid Image ;   Maëlys Bresson1 Author Orcid Image ;   Giacomo Gravante1 Author Orcid Image ;   Sophie Cortese1 ;   Emilie Beulque1 Author Orcid Image ;   Fadila Chergui1 ;   Alexandre Harlé1 Author Orcid Image ;   Gilles Dolivet1, 2 Author Orcid Image
Article Authors Cited by Tweetations Metrics

Romina Mastronicola   1, 2 , PhD ;   Maëlys Bresson   1 , MSPH ;   Giacomo Gravante   1 , MD ;   Sophie Cortese   1 , MD ;   Emilie Beulque   1 , MD ;   Fadila Chergui   1 , PharmD ;   Alexandre Harlé   1 , PhD ;   Gilles Dolivet   1, 2 , PhD

1 Head and Neck Department, Institut de Cancérologie de Lorraine, Vandoeuvre les Nancy, Grand Est, France

2 Centre de Recherche en Automatique de Nancy, Vandoeuvre les Nancy, Grand Est, France

Corresponding Author:

  • Maëlys Bresson, MSPH
  • Head and Neck Department
  • Institut de Cancérologie de Lorraine
  • 6 avenue Bourgogne
  • Vandoeuvre les Nancy, Grand Est
  • France
  • Phone: 33 782467069
  • Email: maelys.bresson@outlook.fr